Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion
about
Antiretroviral treatment cohort analysis using time-updated CD4 counts: assessment of bias with different analytic methodsClinical and laboratory characteristics, staging, and outcomes of individuals with AIDS-associated Kaposi's sarcoma at an university hospitalPredictive clinical factors in the diagnosis of gastrointestinal Kaposi's sarcoma and its endoscopic severity.Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort studyCancer biomarkers in HIV patientsThe effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma: results of a match between an AIDS and cancer registry.Factors associated with cancer incidence and with all-cause mortality after cancer diagnosis among human immunodeficiency virus-infected persons during the combination antiretroviral therapy era.Nelfinavir impairs glycosylation of herpes simplex virus 1 envelope proteins and blocks virus maturationMetastatic Kaposi's Sarcoma with Perirectal Involvement Diagnosed with Endoscopic Ultrasound-Guided EchoBrush Cytology Sampling.Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.Visceral Kaposi's Sarcoma Presenting as Upper Gastrointestinal Bleeding.A Prospective Study Assessing Tumour Response, Survival, and Palliative Care Outcomes in Patients with HIV-Related Kaposi's Sarcoma at Queen Elizabeth Central Hospital, Blantyre, Malawi.A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South AfricaLichen Planus-like Keratosis: Another Differential Diagnosis for Kaposi SarcomaImpact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settingsRisk of Kaposi sarcoma during the first months on combination antiretroviral therapyHuman immunodeficiency virus-associated lung malignanciesBurden of Cancers Attributable to Infectious Agents in Nigeria: 2012-2014.Pulmonary Kaposi Sarcoma: An Uncommon Cause of Respiratory Failure in the Era of Highly Active Antiretroviral Therapy-Case Report and Review of the Literature.Kaposi`s sarcoma associated herpesvirus infection among female sex workers and general population women in Shanghai, China: a cross-sectional study.Hepatic Kaposi sarcoma: A case report and review of the literature.Do we still need chemotherapy for AIDS-associated Kaposi's sarcoma?Review of latent and lytic phase biomarkers in Kaposi's sarcoma.Changing Incidence and Risk Factors for Kaposi Sarcoma by Time Since Starting Antiretroviral Therapy: Collaborative Analysis of 21 European Cohort Studies.Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort.Comparison of Kaposi sarcoma risk in HIV-positive adults across five continents: a multiregional multicohort study.Adrenal incidentaloma in a patient with HIV/AIDS.Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.Estimating time of HIV-1 infection from next-generation sequence diversity.YGLF motif in the Kaposi sarcoma herpes virus G-protein-coupled receptor adjusts NF-κB activation and paracrine actions.The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era.Prevalence and correlates of Kaposi's sarcoma-associated herpesvirus infection in a sample of men who have sex with men in Eastern China.Survival of patients with Kaposi's sarcoma in the South African antiretroviral treatment era: A retrospective cohort study.[Profile of Kaposi sarcoma patients in the competence network HIV/AIDS].
P2860
Q28478065-F8E44485-6D76-48B0-9A57-E615A44E2EBEQ33675703-1FBE82C8-8D6B-4DD0-B43C-FA9648879253Q34504929-3420EDE4-7C52-408B-BCB1-601AE4FE9B34Q34508985-06EEA710-C799-45F5-97F9-009AE5FC3D88Q34661370-AEFA9282-BAC0-4741-B85B-5901A36EE30FQ34952990-B321B286-1905-4970-B724-99CA7A8FEDFFQ35071910-0A3501E0-ABB7-4433-8275-F20D33EC79CCQ35077455-B2756D37-692C-4E36-B59B-EE587AD00472Q35149879-AB27F6C3-FE03-4D52-AB28-88784DB14BD7Q35557475-1FBF5B07-4112-4D00-B9DB-1C3A15819381Q35625790-09E9191E-7C29-48F1-9E1A-4B96362FA9B7Q35846173-C87DCAF3-8177-4099-869B-B8E609377295Q35989731-E7AF1D2E-A7B9-4CCB-8514-22E9BF30B9ECQ36147835-5C85DA84-49A2-4ECC-91D6-94C6B62F352CQ36162341-3F24F86A-4B04-4BB9-838D-CBAFE704FCF1Q36757480-29ADC6BC-7B52-4BFB-988D-81407D69F83BQ36897143-4A6EC6E8-F361-4D81-9005-52D4458DDC73Q37359575-64467374-7E22-4466-9947-D190500C0E2BQ37410777-25B69F74-C9DE-4703-810E-485DD46693F1Q37590921-8E201A08-0A85-4DCD-A399-6CE0FDB2A0C2Q37628536-0F6B965C-9B33-48B7-9C5E-C4282B32F854Q38081246-A59EE630-5025-4758-9FF5-C3EE779B5C25Q38144129-03559EE1-ED72-4A4B-BC2D-230A7CBE1FA5Q38404819-965C85C6-006D-4D82-A9F1-0BF6DD75217BQ38414729-556BD2D2-88DE-4515-BDAE-4C1F6A8F4A38Q38771101-88A2D2D8-2E0A-4BE6-96F0-48627FEC7A82Q40065744-7A74121E-F902-4955-A744-410135B779E1Q40250347-C5C5102B-D337-4642-8DA1-2289E78C8B7EQ41926717-B0BE029E-116E-47E1-8F1C-5899674CB76AQ42251926-E8333E69-06E5-4E22-931E-229C5E2C0CE4Q42278556-C1498BAD-A5C8-4D60-8351-A38387E67A0DQ44565603-521182FD-1349-4EB4-AFAB-D88DA1371C98Q50096998-AF2268CC-931C-4BD0-9940-918E8CFAF82CQ50173084-14BCB764-75BD-45A3-AF8E-AF58DF675615
P2860
Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Kaposi sarcoma incidence and s ...... l men after HIV seroconversion
@ast
Kaposi sarcoma incidence and s ...... l men after HIV seroconversion
@en
type
label
Kaposi sarcoma incidence and s ...... l men after HIV seroconversion
@ast
Kaposi sarcoma incidence and s ...... l men after HIV seroconversion
@en
prefLabel
Kaposi sarcoma incidence and s ...... l men after HIV seroconversion
@ast
Kaposi sarcoma incidence and s ...... l men after HIV seroconversion
@en
P2093
P2860
P50
P356
P1476
Kaposi sarcoma incidence and s ...... l men after HIV seroconversion
@en
P2093
CASCADE Collaboration
Marguerite Guiguet
Martin Fisher
P2860
P304
P356
10.1093/JNCI/DJQ134
P407
P577
2010-05-04T00:00:00Z